CYP19A1 and breast carcinoma: Although several urolithins (at 47 μM) exhibited anti-aromatase activities in a placental microsome-based enzyme assay, only UB competitively inhibited and most effectively suppressed the aromatase activity in an aromatase-overexpressing breast cancer cell line (MCF-7aro) [81].